Documents

Ideas Discussions Technicals Forecast Seasonals

Aprea Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Aprea Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Corporate Presentation

Aug 12, 2025

Slides

Q2 2025

Aug 12, 2025

Quarterly report10-Q

Earnings release8-K

Q1 2025

May 14, 2025

Quarterly report10-Q

Earnings release8-K

Corporate Presentation

May 14, 2025

Slides

2024

Q4 2024

Mar 25, 2025

Slides

Earnings release8-K

Annual report10-K

Corporate Presentation

Nov 07, 2024

Slides

Q3 2024

Nov 07, 2024

Earnings release8-K

Q2 2024

Aug 12, 2024

Quarterly report10-Q

Earnings release8-K

Study Update

Jun 24, 2024

Slides

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 26, 2024

Earnings release8-K

Q3 2023

Nov 09, 2023

Quarterly report10-Q

Earnings release8-K

Study Update

Oct 31, 2023

Slides

Q2 2023

Aug 10, 2023

Earnings release8-K

Q1 2023

May 15, 2023

Earnings release8-K

2022

Q4 2022

Mar 30, 2023

Earnings release8-K

Q3 2022

Nov 09, 2022

Earnings release8-K

Q2 2022

Aug 12, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 16, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 15, 2022

Earnings release8-K

Q3 2021

Nov 08, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 12, 2021

Quarterly report10-Q

Earnings release8-K

Q1 2021

May 06, 2021

Earnings release8-K